Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone
Kristine S. Klos, Xiaoyan Zhou, Sangkyou Lee, Lianglin Zhang, Wentao Yang, Yoichi Nagata, Dihua YuVolume:
98
Year:
2003
Language:
english
Pages:
9
DOI:
10.1002/cncr.11656
File:
PDF, 209 KB
english, 2003